BRAF and neoplasm: Patients that were to have metastasectomy/LAT were slightly younger, had a better ECOG performance status, and more commonly had the primary tumour resected, a left-sided primary, one metastatic site, liver metastases, or a tumour that was RAS/BRAF wild-type, in comparison with systemic therapy only patients (Table 1).